Medical/Pharmaceuticals
AnchorDx Achieves Academic Breakthrough with Deep Methylation Representation Learning Research Paper Accepted by 36th AAAI Conference
GUANGZHOU, China, Dec. 9, 2021 /PRNewswire/ -- AnchorDx, a world-leading developer of cancer screening and early detection solutions, was accepted on December 1, 2021, to present its "Noninvasive Lung Cancer Early Detection via Deep Methylation Representation Learning" research paper (DeepMeth) at...
2021-12-09 22:00
3449
The innovative software "CAAS vFFR" by Pie Medical Imaging for the non-invasive physiological assessment of intermediate coronary lesions is the subject of FAST III, a multicenter European clinical trial which will investigate the effectiveness of the vessel Fractional Flow Reserve (vFFR) guided revascularization as compared to conventional FFR guided revascularization
MAASTRICHT, Netherlands, Dec. 9, 2021 /PRNewswire/ -- Pie Medical Imaging ("PMI"), a global leader in cardiac imaging, part of the Esaote Group, today announced the beginning of FASTIII, a multicenter randomized clinical trial which willinvestigate the use of angiography-based vessel fractional ...
2021-12-09 21:00
3744
Seegene Rapidly Introduces New PCR Test that Identifies the Omicron Variant, its Stealth Version, and all VOCs in a single tube
SEOUL, South Korea, Dec. 9, 2021 /PRNewswire/ -- Seegene Inc. (KQ 096530), South Korea's leading molecular diagnostics company, today unveiled another series of diagnostic test that detects the ever-changing COVID-19 variant landscape. The Novaplex™ SARS-CoV-2 Variants VII assay addresses Omicron...
2021-12-09 20:18
2899
Sciwind Biosciences Completes Enrollment in Phase 2 Clinical Trial of XW003 in Type 2 Diabetes Patients
HANGZHOU, China and SAN FRANCISCO, Dec. 9, 2021 /PRNewswire/ -- Sciwind Biosciences Co., Ltd., a clinical-stage biopharmaceutical company focused on discovering and developing innovative therapies to treat metabolic disease, today announced the completion of patient enrollment in its Phase 2 clin...
2021-12-09 20:00
3407
Another clean interim safety review of RhoVac's clinical phase IIb study in prostate cancer
HELSINKI, Dec. 9, 2021 /PRNewswire/ -- RhoVac AB ("RhoVac"), a Swedish cancer immunotherapy company, announces today onDecember 9th, 2021, that its Data & Safety Monitoring Committee (DSMC) has conducted a planned interim safety review of its clinical phase IIb trial in prostate cancer, known as ...
2021-12-09 16:58
1676
Proximie Partners with Jhpiego in New Initiative to Improve Obstetric Surgical Care
- The Obstetric Safe Surgery (OSS) Project in Kenya is funded by Johnson & Johnson and to date has been implemented by Jhpiego as the lead organization, in collaboration with County and National Ministries of Health and professional associations. - To support implementation moving forward, Proxi...
2021-12-09 15:00
5518
Posters Highlighting clinical data of KN026 presented at SABCS 2021
SUZHOU, China, Dec. 9, 2021 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) and CSPC Pharmaceutical Group Co., Ltd. (stock code: 1093.HK) jointly announced that two posters highlighting data from two clinicalstudies of the anti-HER2 bispecific antibody KN026 were presented at the 44th San...
2021-12-09 12:20
3004
Lunit Named to the 2021 CB Insights Digital Health 150 -- List of Most Innovative Digital Health Startups
SEOUL, South Korea, Dec. 9, 2021 /PRNewswire/ -- CB Insights
2021-12-09 11:24
3030
Positive EMERALD Trial Results for Elacestrant Presented at San Antonio Breast Cancer Symposium 2021
- Trial met both primary endpoints demonstrating statistically significant and clinically meaningful extension of progression free survival (PFS) as monotherapy vs. standard of care (SoC) endocrine therapy in overall population and estrogen receptor mutation (mESR1) population - In the overall p...
2021-12-09 08:38
3661
Servatus raises $7.5 million to advance autoimmune therapies with its microbial biotherapeutics clinical programs
* Servatus has raised $7.5 million in an oversubscribed capital raise, with strong support from sophisticated shareholders * Funds raised will underpin Servatus' live microbial and engineered protein biotherapeutics drug development * Two Phase 1/2 clinical trials to launch shortly in Queens...
2021-12-09 07:35
3724
Brii Bio Announces Amubarvimab/Romlusevimab Combination Received Approval from NMPA as First COVID-19 Neutralizing Antibody Combination Therapy in China
The approval marks the first locally-discovered and approved SARS-CoV-2 target-specific treatment inChina, through a randomized, double-blind and placebo-controlled trial Brii Bio is also seeking U.S. FDA Emergency Use Authorization for the amubarvimab/romlusevimab combination DURHAM, N.C. and ...
2021-12-09 06:10
4473
CRI Online: China's Fangchenggang City Hosts 2021 IMICF
FANGCHENGGANG, China, Dec. 8, 2021 /PRNewswire/ -- A news reported by CRI
Online:
On December 6, the 2021 International Medical Innovation Cooperation Forum
was held in Fangchenggang City,Guangxi Province online and offline.
2021-12-08 21:17
5186
Donisi Health Takes Home First Place in the Prestigious Innovations in Cardiovascular Intervention Competition
MedTech Startup Focused on Home Monitoring for Patients with Congestive Heart
Failure and Other Chronic Diseases Wins the 2021 ICI Pitch Competition and
$200,000 Award
TEL AVIV, Israel, Dec. 8, 2021 /PRNewswire/ -- Donisi Health
2021-12-08 21:01
2825
Treadwell Therapeutics Announces A Presentation at the 2021 SABCS Annual Meeting Featuring a Clinical Trial Update on CFI-402257, a Best-in-Class TTK inhibitor
NEW YORK and HONG KONG, Dec. 8, 2021 /PRNewswire/ -- Treadwell Therapeutics, today announced a presentation for the Company's CFI-402257 program, an oral, best-in-class TTK inhibitor, at the 2021 San Antonio Breast Cancer Symposium (SABCS) being held from December 7-10, 2021. This presentation w...
2021-12-08 20:00
3475
China's Largest Commercial GMP Plasmid Manufacturing Facility is Put into Operation, GenScript ProBio Expanding Manufacturing Capacity Again
NANJING, China, Dec. 8, 2021 /PRNewswire/ -- On December 7th, the "Opening Ceremony of GenScript ProBio Plasmid Commercial GMP Manufacturing facility and Open Day" was rounded off. GenScript ProBio at the opening ceremony announced thatthe largest commercial GMP plasmid manufacturing facility in ...
2021-12-08 18:22
3835
AXA Hong Kong launched exclusive mind health network and online counselling service for Employee Benefits customers
HONG KONG, Dec. 8, 2021 /PRNewswire/ -- As a leading Employee Benefits insurance provider, AXA Hong Kong (AXA) continuously enhances its services to working individuals with a commitment to safeguarding all aspects of their physical and mental wellbeing. To enhance mental health support and to ma...
2021-12-08 18:00
3242
SHL Medical Publishes its Molly Modular Autoinjector Platform Technology White Paper
ZUG, Switzerland, Dec. 8, 2021 /PRNewswire/ -- SHL Medical, a world-leading solutions provider in the design, development, and manufacturing of self-injection devices, announced the publication of its white paper titled, "Molly® Autoinjector: A Systematic Review of Molly's Integrated and Flexible...
2021-12-08 14:00
5404
GSK Provides Update on Manufacturing Operations in Singapore
SINGAPORE, Dec. 8, 2021 /PRNewswire/ -- GSK announced today that it will cease manufacturing and outsource all production of amoxicillin that is currently produced at its Quality Road site inSingapore. Amoxicillin is an active pharmaceutical ingredient (API) in GSK's Augmentin product. This will ...
2021-12-08 09:30
4769
Henlius' Phase 3 clinical study of novel PD-1 inhibitor serplulimab for the treatment of first-line extensive-stage small cell lung cancer (ES-SCLC) meets primary study endpoint
SHANGHAI, Dec. 8, 2021 /PRNewswire/ -- Shanghai Henlius Biotech, Inc. (2696.HK) announced that the first interim analysis met the primary study endpoint of the overall survival (OS) of the Phase 3 clinical study (NCT04063163) of its innovative PD-1 inhibitor serplulimab in combination with chemot...
2021-12-08 08:30
4247
Venus Medtech Acquires Cardiovalve to Optimize its Innovative Products Pipeline of Mitral and Tricuspid Valve Replacement
HANGZHOU, China, Dec. 8, 2021 /PRNewswire/ -- Venus Medtech (Hangzhou) Inc. (Venus MedTech, 2500.HK), a leading, innovative Chinese structural heart disease treatment company, announced its acquisition of Cardiovalve Ltd. (Cardiovalve), a pioneering transcatheter mitral and tricuspid valve treatm...
2021-12-08 08:28
5030
Week's Top Stories
Most Reposted
Agoda Releases AI Developer Report 2026: Agentic AI Adoption Outpaces Enterprise Readiness Across Southeast Asia and India
[Picked up by 292 media titles]
2026-09-24 10:30
CityUHK and University of Cambridge establish Centre for Advanced and Smart Manufacturing to shape Hong Kong's Industry 5.0 future
[Picked up by 291 media titles]
2026-09-22 18:37
CGS International Convenes China-ASEAN Business Leaders Summit to Deepen Capital Connectivity Across the Corridor
[Picked up by 279 media titles]
2026-09-23 09:00
01F Group Announces Investment in DANA, Indonesia's Leading Digital Financial Company, Reinforcing Long-Term Confidence in Asia's Fintech Opportunity
[Picked up by 275 media titles]
2026-09-21 08:00Malaysia Calls for Shift from Halal-Certified to Halal-Competitive as ASEAN Targets USD5 Trillion Global Halal Economy
[Picked up by 275 media titles]
2026-09-25 14:45
Most Read
Brightray Signs Prefabricated Module Sales Framework Agreement for Planned 40MW AI Data Center Project in Macao
2026-09-25 20:30
10865
Envision Energy Secures TÜV SÜD Certificate for Wind Farm Control System, Strengthening Long-Term Resilience for Future Energy Systems
2026-09-25 20:11
10825
Dreame Technology Opens New Flagship Store at Suntec City, Expanding Smart Living Experience in Singapore
2026-09-25 18:33
9750
